2026-7-6Urokinatide is a natural glycoprotein isolated and purified from the urine of healthy adult males, classified as a broad-spectrum protease inhibitor pharmaceutical active ingredient.
It is a urinary trypsin inhibitor widely used in the treatment of acute pancreatitis and septic shock, capable of inhibiting the activity of various proteases and suppressing cytokine release.